Semax

Semax is a synthetic heptapeptide with the amino-acid sequence Met-Glu-His-Phe-Pro-Gly-Pro. It contains the ACTH (4–7) fragment joined to the Pro-Gly-Pro tripeptide and is studied in neurological, neurotrophic and cellular-signalling research.

Product Features

• Synthetic seven-amino-acid research peptide
• Suitable for controlled laboratory and analytical studies
• Commonly investigated in neurological and cellular-signalling models
• Supplied in securely sealed and clearly labelled packaging
• Intended for handling by qualified research professionals

Research Applications

Semax has been examined in laboratory and limited human research involving:

• Neurotrophic signalling pathways
• Brain-derived neurotrophic factor activity
• Gene-expression responses
• Neurological stress and ischemia models
• Cognitive and neuronal-network research

Its biological mechanisms are not yet fully understood, and much of the published evidence comes from animal, laboratory or small exploratory human studies.

Storage

Store according to the conditions stated on the product label or certificate of analysis. Keep the container securely sealed and protected from excessive heat, moisture and direct sunlight.

Important Notice

Semax is not an FDA-approved medicine in the United States. The FDA has scheduled Semax-related bulk substances for discussion at its Pharmacy Compounding Advisory Committee meeting on July 23–24, 2026; evaluation for pharmaceutical compounding does not constitute approval or confirmation of safety or effectiveness.

This product must not be promoted as a treatment for stroke, memory problems, cognitive impairment, neurological disorders or any other medical condition.

For laboratory research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease.